US2009238861A1PendingUtilityA1

Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl

Assignee: MYLAN PHARMACEUTICALS INCPriority: Oct 30, 2002Filed: Jun 2, 2009Published: Sep 24, 2009
Est. expiryOct 30, 2022(expired)· nominal 20-yr term from priority
Y10T156/10A61P 25/04A61K 9/7069A61K 31/445
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Silicone adhesive formulations are provided, in which fentanyl particles are suspended one or more a solvated silicone adhesives. The formulations can be used for manufacturing improved, matrix-type transdermal devices for administering fentanyl.

Claims

exact text as granted — not AI-modified
1 . A monolithic transdermal patch comprising:
 (a) a backing layer having inner and outer surfaces; and   (b) a first adhesive layer having a first surface covering at least a portion of said inner surface of said backing layer,   said adhesive layer comprising a therapeutically-effective amount of fentanyl in an adhesive, wherein less than 1% of said fentanyl can be dissolved in said adhesive when said adhesive is fully solvated with a solvent capable of fully solvating or dissolving said adhesive.   
     
     
         2 - 20 . (canceled)

Join the waitlist — get patent alerts

Track US2009238861A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.